Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 2216-2219

  Shabtai, M ^a   Ye, H ^a   Frischer, Z ^a   Martin, J ^a   Waltzer, W C ^a   Malinowski, K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Blood; Carcinoma, renal cell; Immune system; Kidney; Tumor infiltrating lymphocytes

Indexed keywords

BIOCHEMICAL MARKER; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD LEVEL; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL SURFACE; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NEPHRECTOMY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE LEVEL;

EID: 0036837654     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64358-3     Document Type: Article

References (28)

1. Schendel, B. J., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Reithmuller, G. et al: Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol, 151: 4209, 1993
2. Bouet-Toussaint, F., Genetel, N., Rioux-Leclercq, N., Bansard, J. Y., Leveque, J., Guille, F. et al: Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer. Eur Cytokine Netw, 11: 217, 2000
3. Van den Hove, L. E., Van Gool, S. W., Van Poppel, H., Baert, L., Coorevits, L., Van Damme, B. et al: Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumor-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol, 109: 501, 1997
4. Steiner, T., Junker, U., Wunderlich, H. and Schubert, J.: Are renal cell carcinoma cells able to modulate the cytotoxic effect of tumor infiltrating lymphocytes by secretion of interleukin-6? Anticancer Res, 19: 1533, 1999
5. Akdis, C. A. and Blaser, K.: Mechanisms of interleukin-10-mediated immune suppression. Immunology, 103: 131, 2001
6. Kanda, M.: Gangliosides GD1a and GM3 induce interleukin-10 production by human T cells. Biochem Biophys Res Commun, 256: 41, 1999
7. Irani, D. N., Lin, K. I. and Griffin, D. E.: Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J Immunol, 157: 4333, 1996
8. Uzzo, R. G., Rayman, P., Kolenko, V., Clark, P. E., Bloom, T., Ward, A. M. et al: Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res, 5: 1219, 1999
9. Brasanac, D., Muller, C. A., Muller, G. A., Hadzi-Dzokic, J. and Markovic-Lipovski, J.: HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation. J Exp Clin Cancer Res, 18: 505, 1999
10. Brasanac, D., Markovic-Lipovski, Hadzi-Dzokic, J., Muller, G. A. and Muller, C. A.: Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data. Neoplasma, 46: 173, 1999
11. Lee, K. H., Panelli, M. C., Kim, C. J., Riker, A. I., Bettinotti, M. P., Roden, M. M. et al: Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol, 161: 4183, 1998
12. Zuber, M., Filgueira, L., Merlo, A., Luscher, U., Juretic, A., Spagnoli, G. et al: [Tumor-immune system interaction in renal cell carcinoma and melanomas. Cytokine transcription in tumors at the time of surgical resection.] Schweiz Med Wochenschr, 124: 930, 1994
13. Coventry, B. J., Weeks, S. C., Heckford, S. E., Sykes, P. J., Bradely, J. and Skinner, J. M.: Lack of IL-2 cytokine expression despite IL-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers. J Immunol, 156: 3486, 1996
14. Malinowski, K., Kono, K., Takayama, T., Terashima, T., Tsukuda, K., Walzer, W. et al: Inhibition of lymphocyte proliferative responses by renal cell carcinoma extract. Transplant Proc, 29: 839, 1997
15. Lu, P. and Sharom, F. J.: Immunosuppression by YAC-1 lymphoma: role of shed gangliosides. Cell Immunol, 173: 22, 1996
16. Razani-Boroujerdi, S., Edwards, B. and Sopori, M. L.: Lead stimulates lymphocyte proliferation through enhanced T cell-B cell interaction. J Pharmacol Exp Ther, 288: 714, 1999
17. Chadburn, A., Inghirami, G. and Knowels, D. M.: The kinetics and temporal expression of T cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1) EMA and CD11c (LeuM5) by benign activated T cells. Hematol Pathol, 6: 193, 1992
18. Van den Hove, L. E., Van Gool, S. W., Van Poppel, H., Baert, L., Coorevits, L., Van Damme, B. et al: Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma. Int J Cancer, 71: 178, 1997
19. Lucivero, G., Dalla Mora, L., Bresciano, E., Loria, M. P., Pezone, L. and Mancino, D.: Functional characteristics of cord blood T lymphocytes after lectin and anti-CD3 stimulation. Differences in the way T cells express activation molecules and proliferate. Int J Clin Res, 26: 255, 1996
20. Rodriguez, M. A., De Sanctis, J. B., Blasini, A. M., Leon-Ponte, M. and Abadi, I.: Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes. Immunology, 69: 554, 1990
21. Bayer, A. L., Baliga, P. and Woodward, J. E.: Differential effects of transferrin receptor blockade on cellular mechanisms involved in graft rejection. Transplant Immunol, 7: 131, 1999
22. Bayer, A. L., Baliga, P. and Woodward, J. E.: Transferrin receptor in T cell activation and transplantation. J Leukocyte Biol, 64: 19, 1998
23. Schowengerdt, K. O., Fricker, F. J., Bahjat, K. S. and Kuntz, S. T.: Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection. Transplantation, 69: 2102, 2000
24. Whiteside, T. L. and Herberman, R. B.: The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol, 7: 704, 1995
25. Hayakawa, K., Morita, T., Augustus, L. B., von Eschenbach, A. C. and Itho, K.: Human renal cell carcinoma cells are able to activate natural killer cells. Int J Cancer, 51: 290, 1992
26. Stanley, A. J., Gough, M. J., Banks, R. E., Selby, P. J. and Patel, P. M.: Renal cell carcinoma lines inhibit natural killer activity via the CD94 receptor molecule. Cancer Immunol Immunother, 50: 260, 2001
27. Fortis, C., Ferraro, E., Besana, C., Biffi, M., Heltai, S., Galli, L. et al: Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunol Immunother, 32: 161, 1990
28. Sica, D., Rayman, P., Stanley, J., Edinger, M., Tubbs, R. R., Klein, E. et al: Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer, 53: 941, 1993.